.png){kind=logo}
Your Device Is FDA-Cleared. Who Is Your U.S. Initial Importer?
A 510(k) clearance or a registered listing proves your device may be marketed in the United States. It does not answer a different question that comes up the moment your first shipment arrives: who in the U.S. is accountable for that device, and what happens if something goes wrong?
That accountability sits with the FDA Initial Importer. Many foreign manufacturers treat it as a registration formality. It is closer to a standing commitment.
Consider a case described in an October 2026 industry article by Team Global Logistics. A Taiwanese infusion-set manufacturer spent two years and a meaningful budget earning its 510(k) clearance. The clearance letter arrived, the first order came in from a U.S. distributor, and the goods shipped. Then the entry sat at the Port of Los Angeles under an FDA hold for eleven days. The reasons reported: the manufacturer's registration number was entered in the wrong field, the product code filed could not be matched to the device listing and marketing clearance, and nobody on either side of the Pacific could say who was responsible for fixing it.
The device was cleared. What was missing was a named owner for what happens at the border and after it. The article doesn't say whether an Initial Importer was in place, but the gap it describes is exactly the one a clearly designated, registered Initial Importer closes: a U.S. establishment that FDA can reach, that carries the postmarket duties, and whose responsibilities are written down before the first shipment.
What an Initial Importer is
Under 21 CFR 807.3(g), an Initial Importer is the U.S. establishment that furthers the marketing of a foreign-made device to the party that makes the final delivery or sale to the user, without repackaging or changing the container, wrapper or labeling.
Three practical points follow:
It must be a U.S. establishment with a physical address. A foreign manufacturer cannot be its own Initial Importer.
It must register with FDA every year. The renewal window runs October 1 to December 31, and the FY2027 establishment registration fee is $13,785 per establishment. The fee has no small-business discount; FDA can waive a renewal fee only for qualifying small businesses that show financial hardship.
The role follows the facts of your supply chain. If a U.S. company buys your device and resells it unchanged, that company is likely your Initial Importer whether or not anyone planned it that way.
What it carries after the device clears
Registration is the easy part. The ongoing duties are where the weight is:
Medical Device Reporting (21 CFR 803). If the importer learns a device may have caused or contributed to a death or serious injury, it reports to FDA and the manufacturer; malfunctions that could do so if they recur are reported to the manufacturer. Timeline: no later than 30 calendar days after becoming aware.
Corrections and Removals (21 CFR 806). When the importer initiates a correction or removal to reduce a health risk, a report is due within 10 working days where FDA's criteria apply. Actions below the reporting threshold still need records.
Tracking (21 CFR 821) for devices where it applies.
Complaint files and distribution records, kept so they can be produced on request.
Inspection readiness. Initial importers are inspectable establishments, and FDA expects the requirements of the quality system regulation that apply to their operations to be met.
Manufacturers also carry their own duties for adverse events and recalls. The importer does not replace them, which is why the two sides need a written agreement on who receives complaints, who assesses reportability and who files.
Why it surfaces at the port
When a shipment arrives, FDA compares what the entry declares against its records: the manufacturer's registration number, the device listing, the product code and the premarket authorization. FDA's own list of common entry errors includes a product code that doesn't match the listing and a registration number that doesn't match the listing it was transmitted with. A manufacturer must also identify its known importers to FDA at registration and each year after.
None of that requires a dramatic failure. A number in the wrong field, a stale registration, or an importer who isn't set up for the role can be enough to trigger further review. If nobody clearly owns the fix, a clerical error turns into storage fees, delayed deliveries and awkward calls with your distributor.
Three roles that get confused
Role | What it does | Who can hold it |
Importer of Record | Files the customs entry; responsible for classification, value and duties | The owner, purchaser or a licensed customs broker; a foreign company can act in some cases |
FDA Initial Importer | Registered with FDA; carries postmarket duties (MDR, corrections and removals, records) | A U.S. establishment only |
U.S. Agent | Your contact point with FDA for communications and inspection scheduling | A person or firm with a U.S. address; required for every foreign establishment |
One company can hold more than one of these. They are still three separate responsibilities.
Your options
Foreign manufacturers usually choose among three structures:
Your distributor acts as Initial Importer. Quick to start, but many distributors don't want FDA registration or postmarket duties, and you depend on their quality procedures.
You set up your own U.S. entity. Maximum control, with real cost: formation, a staffed U.S. address, annual FDA registration and fee, a quality system, and people who can run complaint handling and MDR.
You use a specialist Initial Importer. A dedicated firm holds the registration and carries the role's duties, so you don't build the infrastructure yourself.
There is no universal right answer. There is a right answer for your volume, margin and plans for the U.S. market.
Where Provision Consulting Group fits
Provision Consulting Group, a U.S. FDA consulting firm founded in 2015, serves as the Initial Importer for foreign medical device manufacturers. We hold the Initial Importer registration and carry the role's regulatory duties, including adverse event reporting, corrections and removals, complaint handling and records, and inspection readiness. Because we take the role, you avoid setting up a U.S. entity and avoid registering and paying FDA's annual fee for an importer establishment of your own.
For inquiries or expert assistance, please contact us today.
CONTACT US
Office: 1-909-493-3276
Email: ask@provisionfda.com